Differential expression of VEGFR2protein in HER2 positive primary human breastcancer: potential relevance to anti‑angiogenictherapies
Abstract Background: Clinically relevant predictive biomarkers to tailor anti-angiogenic therapies to breast cancer (BRC) patient subpopulations are an unmet need.Methods: We analyzed tumor vascular density and VEGFR2 protein expression in…